HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yuzhi Jin Selected Research
Yuzhi Jin Research Topics
Disease
6
Neoplasms (Cancer)
04/2024 - 01/2021
2
Hepatocellular Carcinoma (Hepatoma)
02/2024 - 09/2023
2
Pancreatic Neoplasms (Pancreatic Cancer)
09/2023 - 01/2021
1
Neoplasm Metastasis (Metastasis)
04/2024
1
Lung Neoplasms (Lung Cancer)
04/2024
1
Adenocarcinoma of Lung
04/2024
1
Colorectal Neoplasms (Colorectal Cancer)
01/2023
1
Inflammation (Inflammations)
01/2022
1
Cholangiocarcinoma
01/2022
1
Ischemia
09/2019
1
Necrosis
09/2019
Drug/Important Bio-Agent (IBA)
2
RNA (Ribonucleic Acid)
IBA
04/2024 - 01/2022
2
Apolipoproteins E (ApoE)
IBA
04/2024 - 01/2022
2
Immune Checkpoint Inhibitors
IBA
04/2024 - 02/2023
2
Irinotecan (Camptosar)
FDA Link
Generic
02/2023 - 01/2021
1
Collagen
IBA
04/2024
1
Biomarkers (Surrogate Marker)
IBA
02/2024
1
Emulsions
IBA
09/2023
1
Lipase (Acid Lipase)
FDA Link
09/2023
1
Fluorouracil (Carac)
FDA Link
Generic
02/2023
1
Small Cytoplasmic RNA
IBA
01/2022
1
Capecitabine (Xeloda)
FDA Link
01/2021
1
Gemcitabine
FDA Link
01/2021
1
Albumins
IBA
01/2021
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2021
1
Kallikreins (Kallikrein)
IBA
09/2019
1
Saline Solution
IBA
09/2019
Therapy/Procedure
5
Immunotherapy
04/2024 - 01/2022
2
Therapeutics
04/2024 - 01/2021
1
Injections
09/2023
1
Drug Therapy (Chemotherapy)
01/2022
1
Neoadjuvant Therapy
01/2021
1
Precision Medicine
01/2021